Wilbert B. van Den Hout

Wilbert B. van Den Hout

Auto-generated profile, based on publicly available information

Wilbert B. van Den Hout

Department of Biomedical Data Science, Leiden University Medical Center, Leiden, The Netherlands

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2024
Verified
Conference Paper
Open access
GMGiovane C. M. Moura
Giovane C. M. Moura
TDThomas Daniels
Thomas Daniels
MBMaarten Bosteels
Maarten Bosteels
SCSebastian Castro
Sebastian Castro
MMMoritz Müller
Moritz Müller
GSGeorgios Smaragdakis
Georgios Smaragdakis
Phishing on the web is a model of social engineering and an attack vector for getting access to sensitive and financial data of individuals and corporations. Phishing has been identified as one of the prime cyber threats in recent years. With the goal to effectively identify and mitigate phishing as early as possible, we present in this paper a longitudinal analysis of phishing attacks from the vantage point of three country-code top-level domain (ccTLD) registries that manage more than 8 million active domains -- namely the Netherlands' .nl, Ireland's .ie, and Belgium's .be. We perform a longitudinal analysis on phishing attacks spanning up to 10 years, based on more than 28 thousand phishing domains. Our results show two major attack strategies: national companies and organizations are far more often impersonated using malicious registered domains under their country's own ccTLD, which enables better mimicry of the impersonated company. In stark contrast, international companies are impersonated using any domains that can be compromised, reducing overall mimicry but bearing no registration and financial costs. Although most research works focus on detecting new domain names, we show that 80% of phishing attacks in the studied ccTLDs employ compromised domain names. We find banks, financial institutions, and high-tech giant companies at the top of the most impersonated targets. We also show the impact of ccTLDs' registration and abuse handling policies on preventing and mitigating phishing attacks, and that mitigation is complex and performed at both web and DNS level at different intermediaries. Last, our results provide a unique opportunity for ccTLDs to compare and revisit their policies and impacts, with the goal of improving mitigation procedures.

26 May 2026 in PharmacoEconomics
Verified
Journal Article
Open access
PDF file
AHAnna L. Heilig
Anna L. Heilig
WHWilbert B. van Den Hout
Wilbert B. van Den Hout
MMM. Elske van den Akker-van Marle
M. Elske van den Akker-van Marle
Background and Objective Remote patient monitoring has shown promising outcomes, such as improved disease awareness and reduced hospital stay. However, assessing the cost of the remote patient monitoring itself is challenging owing to the lack of standardization and transparency in economic evaluations of remote patient monitoring. This review aims to identify and compare the cost components used to estimate the remote patient monitoring intervention costs and the reported challenges in assessing them. Methods We performed a scoping review of studies published in PubMed, Embase, and Web of Science that conducted an economic evaluation of a remote patient monitoring between January 2019 and March 2026. Titles and abstracts were screened. Relevant articles were subjected to full-text screening to assess eligibility, and reported cost components were counted based on predefined categories. Difficulties reported by the economic evaluation authors (challenges) were extracted and analyzed using thematic synthesis. Results A total of 1282 articles were identified, of which 84 studies met the eligibility criteria. Forty-nine (58%) studies had an observational design, and the remaining studies had a model design. Components of remote patient monitoring intervention costs were reported in 71 (85%) of the included studies, with staff salaries (62%) and equipment/technology (56%) costs being the most frequently reported. The most commonly reported challenge was uncertainty about which remote patient monitoring cost categories to include. Conclusions This review highlights the disparities in the assessment and reporting of remote patient monitoring intervention costs in economic evaluations. We offer an updated checklist and guidance for assessing and reporting intervention costs in future economic evaluations.